Related Experiment Videos
Prostate epithelial stem cells
S Rizzo1, G Attard, D L Hudson
1The Bob Champion Prostate Stem Cell Laboratory, Institute of Cancer Research, 15 Cotswold Road, Sutton, Surrey, UK, SM2 5NG.
Cell Proliferation
|November 23, 2005
Summary
Prostate cancer may originate from stem cells expressing CD133 but lacking androgen receptors. Research explores the evidence and maintenance of these prostate cancer stem cells.
Area of Science:
- Oncology
- Cell Biology
- Urology
Background:
- Prostate cancer is a leading cancer diagnosis in men.
- Cancer development is often linked to stem cells.
- Normal prostate stem cells exhibit basal cell phenotype and CD133 expression.
Purpose of the Study:
- To review evidence for prostate cancer stem cells.
- To discuss mechanisms of prostate cancer stem cell maintenance.
- To investigate CD133 expression in prostate cancer stem cells.
Main Methods:
- Literature review of existing studies.
- Analysis of preliminary data on prostate cancer stem cells.
- Examination of cell surface marker expression (CD133, androgen receptor).
Main Results:
- Prostate cancer stem cells may express CD133.
- These cancer stem cells appear to lack androgen receptor expression.
- Evidence supports the existence of a distinct prostate cancer stem cell population.
Conclusions:
- Prostate cancer stem cells represent a potential origin for the disease.
- Understanding these cells is crucial for developing targeted therapies.
- Further research is needed to elucidate stem cell maintenance pathways.